Muco-ciliary Cleansing of Lungs in COPD With and Without a Salt Particle Inhaler
NCT ID: NCT03927365
Last Updated: 2021-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
35 participants
INTERVENTIONAL
2018-10-01
2021-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I)
NCT03093974
Effects of Inhaled Corticosteroids on Sputum Bacterial Load in COPD
NCT01213693
A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.
NCT00808288
A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0359-016)
NCT00482235
Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036)
NCT00387036
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Salt particle inhaler with content
Participants inhaling from a salt particle inhaler with content
Inhalation from a salt particle inhaler with or without content
Inhalation from inhaler with (active) or without (placebo) content
Salt particle inhaler without content
Participants inhaling from a salt particle inhaler without content
Inhalation from a salt particle inhaler with or without content
Inhalation from inhaler with (active) or without (placebo) content
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inhalation from a salt particle inhaler with or without content
Inhalation from inhaler with (active) or without (placebo) content
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients exposed to radionuclear isotopes within one month
* Patients under antibiotic treatment
* Patients with known hyper reactive airways
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Liita Care ApS
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jann Mortensen, MD Professor
Role: PRINCIPAL_INVESTIGATOR
Rigshospitalet, Clin Nuclear & Physiolog dept.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rigshospitalet, Clin nuclear and physiolog dept.
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LC.001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.